The vision of Life Science Leader is to be an essential business tool for life science executives. Our content is designed to not only inform readers of best practices, but motivate them to implement those best practices in their own businesses.
Issue link: https://lifescienceleadermag.epubxp.com/i/85321
Sandoz GmbH Kundl, Tirol, Austria www.sandoz.com DRUG TYPE: Pharmaceuticals and Biopharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development – clinical (phase 1, phase 2, and phase 3) Drug Substance Production – primary process development and drug substance production SERVICES OFFERED: Aseptic fill/finish, cytotoxic & high-potency compounds, generics, injectables, liquids, peptides, proteins, and small molecules. "We are delighted to be a recipient of the 2012 CMO Leadership Awards and sincerely thank our customers for this honor. Sandoz is proud of its strong heritage in contract manufacturing services. We have over 60 years of experience in the manufacturing of fermentation-derived intermediates and APIs across various therapeutic areas — as well as process enzymes — and over 30 years of experience in development and manufacturing of recombinant proteins and peptides (microbial and mammalian). Central to our success are our talented people who take a collaborative approach with our customers by offering end-to-end support by helping them develop and commercialize important medicines." — Friedrich Nachtmann, head of biotech corporations, and Gerhard Santer, head of global development & strategy Siegfried AG Zofingen, Argau, Switzerland www.siegfried.ch 0041 62 7461520 DRUG TYPE: Pharmaceuticals and Biopharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development – clinical (phase 1, phase 2, and phase 3) Drug Substance Production – primary process development and drug substance production Formulated Drug Production – dosage form development, dosage form production, packaging, and logistics SERVICES OFFERED: Aseptic fill/finish, capsules, cartridges, controlled substances, creams & ointments, cytotoxic & high-potency compounds, gels, generics, injectables, liquids, non-sterile, ophthalmics, parenterals (small volume), peptides, powders (sterile), proteins, semisolids, solid dose, solutions & suspensions, sterile, sustained release, topicals, and vaccines. "Finding the right outsourcing relationship is critical for pharmaceutical companies today. At Siegfried we share their belief in high quality, innovation, productivity, and compliance. Siegfried, together with AMP, provides products and tailor-made services which seamlessly integrate our customers' value chain. Whether it's custom development services, producing APIs and drug products (oral or sterile), or controlled substances and higher potency you desire, I am convinced you can expect more with Siegfried as your preferred integrated-partner." — Dr. Rudolf Hanko, CEO Manufacturing locations: Malta, Switzerland, and United States Contact: Marianne Späne marianne.spaene@siegfried.ch DRUG TYPE: Pharmaceuticals and Biopharmaceuticals Manufacturing locations: Austria and Germany DRUG TYPE: Pharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development – discovery, pre-clinical, & clinical (phase 1, phase 2, & phase 3) Drug Substance Production – primary process development and drug substance production SERVICES OFFERED: Generics, lyophilized products, and peptides. Senn Chemicals AG Dielsdorf, Switzerland www.sennchem.com +41 (0)43 422 2400 Manufacturing location: Dielsdorf, Switzerland Contact: Elizabeth Hoffner Sales@sennchem.com "Senn is committed to continuous innovation and quality excellence. Our flexible infrastructure allows us to provide viable and inventive custom manufacturing solutions. We work with our clients to develop project plans that facilitate efficient productions, realistic timelines, while adher- ing to set budgets. We are truly grateful to be acknowledged by our global clients with this CMO Leadership Award. We appreciate this very meaningful honor as it exemplifies our commitment to innovative excellence." — Carlo Hächler, CEO Therapure Biopharma Inc. Mississauga, Ontario, Canada www.therapurebio.com (905) 286-6270 Manufacturing location: Mississauga, Ontario, Canada Contact: Dina Iezzi, director of marketing & special projects diezzi@therapurebio.com DRUG LIFE CYCLE STAGES: Research & Development – discovery, pre-clinical, & clinical (phase 1, phase 2, & phase 3) Drug Substance Production – primary process development and drug substance production Formulated Drug Production – dosage form production, packaging, and logistics SERVICES OFFERED: Aseptic fill/finish, injectables, lyophilized products, ophthalmics, parenterals (small volume), proteins, sterile, syringes (pre-filled), and vaccines. "Once again, we are privileged to receive the CMO Leadership award and honoured to be recognized by biopharma executives surveyed by Nice Insight as a leader in all categories (quality, reliability, innovation, productivity, and regulatory). I would like to take this opportunity to thank all the employees of Therapure, whose daily contributions and diligence are the driving force behind our company's success as well as our clients, without whom this would not have been possible." — Nick Green, president and CEO The CMO Leadership Awards 2012 47 DRUG LIFE CYCLE STAGES